MarginsXMarginsX
Home › Markets › Health Care › FOCL

EDAP TMS S.A. (FOCL)

FOCL trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.17
-2.39% on the day
Market cap
$149.7M
Micro cap
Revenue · 2025
$70.5M
+1.6% on 2024
Net income · 2025
-$29.2M
-41.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/0001104659-26-034528-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerFOCL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryFrance
IPO yearNot reported by the screener
SEC CIK0001041934
SEC industry codeElectromedical & Electrotherapeutic Apparatus

Financials · 2025

LineValue
Revenue$70.5M
Net income-$29.2M
Operating income-$24.7M
Net margin-41.5%
Operating margin-35.0%
Revenue growth+1.6%
Cash$20.5M
Total assets$79.0M
P/E (computed)Net income was not positive
P/S (computed)2.1×

Warning signs

Cash runway
51.4 months
$56.3M cash at September 30, 2026
Share count, 1 year
No year-earlier count
+27.3% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$451K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$56.3M cash; operating cash flow -$3.3M a quarter.Report 2026-09-30
Shares outstandingNo cover-page share count in XBRLCover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-08-12
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG SA, Lyon, FrancePCAOB Form AP 2026-04-28
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $451K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$9.8M-$4.5M-$4.0M$56.3M$36.0M$87.5M10-Q 2026-11-05
Q2 2026
2026-06-30
$13.2M-$14.5M-$3.7M$21.5M$39.9M$85.5M10-Q 2026-08-14
Q1 2026
2026-03-31
$17.8M-$9.1M-$3.0M$15.0M$24.3M$81.8M10-Q 2026-05-07
Q4 2025
2025-12-31
$46.7M-$9.5M-$2.5M$20.5M$22.4M$78.3M10-K 2026-03-25
Q3 2025
2025-09-30
$7.8M-$5.9M-$3.9M$12.4MNo debt tagsNeeds four quarters10-Q 2026-11-05
Q2 2025
2025-06-30
$9.5M-$6.4M-$4.7M$19.1MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2025
2025-03-31
$14.3M-$7.4M-$5.3M$24.7MNo debt tagsNeeds four quarters10-Q 2026-05-07

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-08-12
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-05
Latest current report
FORM 8-K
8-K2026-11-05
Latest proxyDEFA14A2026-05-14

Source: SEC EDGAR submissions feed, 497 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.1%
1 month-22.6%
3 months-29.8%
Year to date-1.2%
1 year+53.3%
From 52-week high-48.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
ELMDElectromed Inc.$23.10-5.02%$188.8M
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
STXSStereotaxis Inc.$0.8027-4.80%$80.4M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
CVCapsoVision Inc.$6.47+7.30%$346.9M
OMOutset Medical Inc.$3.39-9.12%$64.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier